IL1R2 is a Novel Prognostic Biomarker for Lung Adenocarcinoma.
Ying ZhangDanyu MaChen Wu
Published in: Current molecular medicine (2023)
According to these findings, we demonstrated that IL1R2 was involved in the progression and prognosis of LUAD and the underlying mechanism needs further investigation.